Demonstration of intermediate cells during human prostate epithelial differentiation in situ and in vitro using triple-staining confocal scanning microscopy

被引:127
作者
van Leenders, G
Dijkman, H
Hulsbergen-van de Kaa, C
Ruiter, D
Schalken, J
机构
[1] Univ Nijmegen, Dept Pathol, Nijmegen, Netherlands
[2] Univ Nijmegen, Dept Urol, Nijmegen, Netherlands
关键词
D O I
10.1038/labinvest.3780133
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In human prostate epithelium, morphologically basal and luminal cells can be discriminated. The basal cell layer that putatively contains progenitor cells of the secretory epithelium is characterized by the expression of keratins (K) 5 and 14. Luminal cells represent the secretory compartment of the epithelium and express K8 and 18. We developed a technique for the simultaneous analysis of K5, 14, and 18 to identify intermediate cell stages in the prostate epithelium and to study the dynamic aspects of its differentiation in vitro. Nonmalignant prostate tissue and primary epithelial cultures were immunohistochemically characterized using triple staining with antibodies for K5, K14, and K18. Antibodies for K18 and K5 were conjugated directly with fluorochromes Alexa 488 and 546. K14 was Visualized indirectly with streptavidin-Cy5. Keratin expression was analyzed by confocal scanning microscopy. The occurrence of exocrine and neuroendocrine differentiation in culture was determined via antibodies to prostate-specific antigen (PSA), chromogranin A, and serotonin. We found that basal cells expressed either K5(++)/14(++)/18(+) or K5(++)/18(+). The majority of luminal cells expressed K18(++), but colocalization of K5(+)/18(++) were recognized. Epithelial monolayer cultures predominantly revealed the basal cell phenotype K5(++)/14(++)/18(+); whereas intermediate subpopulations expressing K5(+)/14(+)/18(++) and K5(+)/18(++) were also identified. On confluence, differentiation was induced as multicellular gland-like buds, and extensions became evident on top of the monolayer. These structures were composed of K18(++)- and K5(+)/18(+)-positive cell clusters surrounded by phenotypically basal cells. Few multicellular structures and cells in the monolayer showed exocrine differentiation (PSA(+)), but expression of chromogranin A and serotonin was absent. We conclude that simultaneous evaluation of keratin expression is useful for analyzing epithelial differentiation in the prostate. During this process, putative stem cells phenotypically resembling K5(++)/14(++)/18(+) differentiate toward luminal cells (K18(++)) via intermediate cell stages, as identified by up-regulation of K18 and down-regulation of K5 and 14.
引用
收藏
页码:1251 / 1258
页数:8
相关论文
共 42 条
[11]   Modulation of cytokeratin subtype, EGF receptor, and androgen receptor expression during progression of prostate cancer [J].
de Medina, SGD ;
Salomon, L ;
Colombel, M ;
Abbou, CC ;
Bellot, J ;
Thiery, JP ;
Radvanyi, F ;
Van der Kwast, TH ;
Chopin, DK .
HUMAN PATHOLOGY, 1998, 29 (09) :1005-1012
[12]   RESPONSE OF GLANDULAR VERSUS BASAL RAT VENTRAL PROSTATIC EPITHELIAL-CELLS TO ANDROGEN WITHDRAWAL AND REPLACEMENT [J].
ENGLISH, HF ;
SANTEN, RJ ;
ISAACS, JT .
PROSTATE, 1987, 11 (03) :229-242
[13]   Anticytokeratin antibody 34 beta E12 staining in prostate carcinoma [J].
Googe, PB ;
McGinley, KM ;
Fitzgibbon, JF .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1997, 107 (02) :219-223
[14]  
Hayward SW, 1996, ACTA ANAT, V155, P81
[15]   The apoptosis cascade - morphological and immunohistochemical methods for its visualization [J].
Huppertz, B ;
Frank, HG ;
Kaufmann, P .
ANATOMY AND EMBRYOLOGY, 1999, 200 (01) :1-18
[16]   DIFFERENTIAL IMMUNOREACTIVITY OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN BENIGN, DYSPLASTIC AND MALIGNANT PROSTATIC TISSUES [J].
IBRAHIM, GK ;
KERNS, BJM ;
MACDONALD, JA ;
IBRAHIM, SN ;
KINNEY, RB ;
HUMPHREY, PA ;
ROBERTSON, CN .
JOURNAL OF UROLOGY, 1993, 149 (01) :170-173
[17]  
ISAACS JT, 1989, PROSTATE S, V2, P33
[18]  
Jarrard DF, 1997, CLIN CANCER RES, V3, P2121
[19]  
Kadkol SS, 1998, PROSTATE, V34, P231, DOI 10.1002/(SICI)1097-0045(19980215)34:3<231::AID-PROS11>3.0.CO
[20]  
2-F